Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.

Ann Intern Med

July 1973

Triglyceride removal efficiency and lipoprotein lipases: effects of Oxandrolone.

Metabolism

June 1973

Clotting mechanisms in patients with hypertriglyceridemia during therapy with anabolic or progestational drugs.

Thromb Diath Haemorrh

May 1973

Plasma and dietary cholesterol in infancy: effects of early low or moderate dietary cholesterol intake on subsequent response to increased dietary cholesterol.

Metabolism

December 1972

Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.

JAMA

November 1972

Musculoskeletal disorders associated with type-IV hyperlipoproteinaemia.

Lancet

September 1972

Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia.

Metabolism

July 1972

Crystalline IgG protein in multiple myeloma: identification effects on coagulation and on lipoprotein metabolism.

J Lab Clin Med

May 1972

Pediatric familial type II hyperlipoproteinemia: effects of diet on plasma cholesterol in the first year of life.

Am J Clin Nutr

February 1972

Progestagens, anabolic-androgenic compounds, estrogens: effects on triglycerides and postheparin lipolytic enzymes.

Lipids

February 1972

Pediatric familial type IV hyperlipoproteinemia.

Trans Assoc Am Physicians

June 1973

Norethindrone acetate, postheparin lipolytic activity, and plasma triglycerides in familial types I, 3, IV, and V hyperlipoproteinemia. Studies in 26 patients and 5 normal persons.

Ann Intern Med

September 1971

Effects of oxandrolone on plasma triglycerides and postheparin lipolytic activity in patients with types 3, IV, and V familial hyperlipoproteinemia.

Metabolism

July 1971

Neonatal familial type II hyperlipoproteinemia: cord blood cholesterol in 1800 births.

Metabolism

June 1971

Familial hyperchylomicronemia. Enzymatic and physiologic studies.

Am J Med

April 1971

A skeletal-muscle disorder associated with intermittent symptoms and a possible defect of lipid metabolism.

N Engl J Med

March 1970

Benign symmetric lipomatosis (Launois-Bensaude adenolipomatosis) with gout and hyperlipoproteinemia.

Am J Med

February 1970

A new mechanism of exogenous hyperglyceridemia.

Ann Intern Med

Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in types II, 3, IV, and V hyperlipoproteinemia.

Diabetes

November 1969

Treatment of hypertriglyceridaemia.

Lancet

October 1969

Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance.

Am J Med

August 1969

Amelioration of hypertriglyceridaemia by progestational drugs in familial type-V hyperlipoproteinaemia.

Lancet

June 1969

Hypertriglyceridemia, diabetes mellitus, and coronary vessel disease.

Arch Intern Med

March 1969

A skeletal muscle disorder associated with intermittent symptoms and a possible defect of lipid metabolism.

Trans Am Neurol Assoc

April 1970

Acute tendinitis and arthritis. A presenting symptom of familial type II hyperlipoproteinemia.

JAMA

December 1968